Jack Adcock, DO
Gynecology · Joplin, MONPI 1669487054
Payments from drug & device makers
What this record shows
This record is dominated by education: $11,674 of the $18,336 with a category attached, or 63.7%. Intuitive Surgical accounts for 75.8% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2022 at $13,615 and has fallen 86.5% since, to $1,836 in 2024.
Across 162 payments — averaging $113.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$14K
- Axonics, Inc.$2K
- AbbVie$673
- Astellas Pharma US Inc$439
- Urovant Sciences Inc$193
- Amgen$182
- plus $918 from 22 others
What the payments were for
- Travel & lodging$3,43219%
- Food & beverage$2,64514%
- Education$11,67464%
- Gifts$5853%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 15 | $13,905 |
| Axonics, Inc. | 17 | $2,026 |
| AbbVie(2 entities) | 39 | $673 |
| Astellas Pharma US Inc | 20 | $439 |
| Urovant Sciences Inc | 7 | $193 |
| Amgen | 11 | $182 |
| Therapeuticsmd, Inc. | 11 | $171 |
| Caldera Medical, Inc | 6 | $153 |
| Coloplast | 5 | $78 |
| Boston Scientific | 4 | $54 |
| Pfizer | 3 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $48 |
| Lupin Inc. | 2 | $40 |
| Valencia Technologies Corporation | 1 | $39 |
| Zyla Life Sciences, Inc. | 2 | $39 |
| Eisai Inc. | 2 | $30 |
| Myovant Sciences Inc. | 1 | $26 |
| Medtronic(2 entities) | 2 | $25 |
| Duchesnay USA Incorporated | 2 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Exeltis, USA Inc. | 1 | $18 |
| Laborie Medical Technologies Corp. | 1 | $17 |
| Convatec Inc. | 1 | $17 |
| Avion Pharmaceuticals | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Organon | 1 | $15 |
| Dysis Medical, Inc. | 1 | $14 |
| Covidien LP | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$11,500
- Da Vinci Surgical System$2,177
- Bulkamid$1,491
- Axonics$1,491
- GEMTESA$108
How this compares
$18,336 in reported general payments places this provider in the 80th percentile of 38 gynecology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 211 | $90,925 |
| GemtesaVibegron | 85 | $54,589 |
| Tolterodine Tartrate ErTolterodine Tartrate | 97 | $4,818 |
| Estradiol | 146 | $3,159 |
| Trospium Chloride | 72 | $2,476 |
| Clobetasol Propionate | 22 | $1,874 |
| Methenamine Hippurate | 58 | $1,278 |
| Clindamycin Phosphate | 21 | $1,260 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 75 | $1,237 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 19 | $683 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 21 | $584 |
| Solifenacin Succinate | 12 | $277 |
| Nystatin | 15 | $254 |
| Oxybutynin Chloride | 26 | $180 |
| Oxybutynin Chloride ErOxybutynin Chloride | 38 | $152 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $439 | $90,925211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 38 gynecology providers in Missouri.
Other gynecology in Joplin
- Terry GrebeJoplin$11
- Corey WagnerSaint Louis$272K
- David LevineSaint Louis$201K
- David RedfernSpringfield$48K
- Richard GimpelsonSaint Louis$28K
- Whitney RossSaint Louis$22K
- Jeffrey PeipertSaint Louis$22K
- David EisenbergSaint Louis$11K
- Robert HusterLiberty$6K
- Kristie LouSaint Louis$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.